Connection

Co-Authors

This is a "connection" page, showing publications co-authored by DAVID S FOLLOWILL and STEPHEN F KRY.
Connection Strength

12.027
  1. Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans. Med Phys. 2019 Aug; 46(8):3700-3708.
    View in: PubMed
    Score: 0.687
  2. Radiation Therapy Deficiencies Identified During On-Site Dosimetry Visits by the Imaging and Radiation Oncology Core Houston Quality Assurance Center. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1094-1100.
    View in: PubMed
    Score: 0.605
  3. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery. Int J Radiat Oncol Biol Phys. 2014 Dec 01; 90(5):1195-201.
    View in: PubMed
    Score: 0.497
  4. Response to Thomsen et al.: Comments on "The Radiological Physics Center's standard dataset for small field size output factors". J Appl Clin Med Phys. 2014 Mar 06; 15(2):4841.
    View in: PubMed
    Score: 0.476
  5. Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing. Int J Radiat Oncol Biol Phys. 2013 Jan 01; 85(1):e95-100.
    View in: PubMed
    Score: 0.438
  6. Ion recombination correction factors (P(ion)) for Varian TrueBeam high-dose-rate therapy beams. J Appl Clin Med Phys. 2012 Nov 08; 13(6):3803.
    View in: PubMed
    Score: 0.434
  7. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy. Med Phys. 2009 Apr; 36(4):1244-50.
    View in: PubMed
    Score: 0.338
  8. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiother Oncol. 2009 Apr; 91(1):132-7.
    View in: PubMed
    Score: 0.333
  9. The Value of On-Site Proton Audits. Int J Radiat Oncol Biol Phys. 2022 03 15; 112(4):1004-1011.
    View in: PubMed
    Score: 0.203
  10. Photon beam modeling variations predict errors in IMRT dosimetry audits. Radiother Oncol. 2022 01; 166:8-14.
    View in: PubMed
    Score: 0.202
  11. Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiother Oncol. 2021 06; 159:106-111.
    View in: PubMed
    Score: 0.194
  12. Evaluation of image quality of a novel computed tomography metal artifact management technique on an anthropomorphic head and neck phantom. Phys Imaging Radiat Oncol. 2021 Jan; 17:111-116.
    View in: PubMed
    Score: 0.193
  13. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys. 2021 Jan; 48(1):445-455.
    View in: PubMed
    Score: 0.190
  14. Sensitivity of IROC phantom performance to radiotherapy treatment planning system beam modeling parameters based on community-driven data. Med Phys. 2020 Oct; 47(10):5250-5259.
    View in: PubMed
    Score: 0.186
  15. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys. 2020 Aug; 21(8):120-130.
    View in: PubMed
    Score: 0.183
  16. Differences in the Patterns of Failure Between IROC Lung and Spine Phantom Irradiations. Pract Radiat Oncol. 2020 Sep - Oct; 10(5):372-381.
    View in: PubMed
    Score: 0.183
  17. Survey results of 3D-CRT and IMRT quality assurance practice. J Appl Clin Med Phys. 2020 Jul; 21(7):70-76.
    View in: PubMed
    Score: 0.182
  18. Reference dataset of users' photon beam modeling parameters for the Eclipse, Pinnacle, and RayStation treatment planning systems. Med Phys. 2020 Jan; 47(1):282-288.
    View in: PubMed
    Score: 0.176
  19. Calibration strategies for use of the nanoDot OSLD in CT applications. J Appl Clin Med Phys. 2019 Jan; 20(1):331-339.
    View in: PubMed
    Score: 0.165
  20. Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance. Phys Med Biol. 2018 10 17; 63(20):205015.
    View in: PubMed
    Score: 0.164
  21. Remote beam output audits: a global assessment of results out of tolerance. Phys Imaging Radiat Oncol. 2018 Jul; 7:39-44.
    View in: PubMed
    Score: 0.163
  22. A New Anthropomorphic Pediatric Spine Phantom for Proton Therapy Clinical Trial Credentialing. Int J Part Ther. 2018; 4(4):20-27.
    View in: PubMed
    Score: 0.161
  23. Reference dosimetry data and modeling challenges for Elekta accelerators based on IROC-Houston site visit data. Med Phys. 2018 May; 45(5):2337-2344.
    View in: PubMed
    Score: 0.158
  24. An FMEA evaluation of intensity modulated radiation therapy dose delivery failures at tolerance criteria levels. Med Phys. 2017 Nov; 44(11):5575-5583.
    View in: PubMed
    Score: 0.153
  25. AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys. 2017 Oct; 44(10):e391-e429.
    View in: PubMed
    Score: 0.151
  26. Development of a Monte Carlo multiple source model for inclusion in a dose calculation auditing tool. Med Phys. 2017 Sep; 44(9):4943-4951.
    View in: PubMed
    Score: 0.151
  27. Development of a flattening filter free multiple source model for use as an independent, Monte Carlo, dose calculation, quality assurance tool for clinical trials. Med Phys. 2017 Sep; 44(9):4952-4960.
    View in: PubMed
    Score: 0.151
  28. Pencil Beam Algorithms Are Unsuitable for?Proton Dose Calculations in Lung. Int J Radiat Oncol Biol Phys. 2017 11 01; 99(3):750-756.
    View in: PubMed
    Score: 0.149
  29. Treatment Planning System Calculation Errors Are Present in Most Imaging and Radiation Oncology Core-Houston Phantom Failures. Int J Radiat Oncol Biol Phys. 2017 08 01; 98(5):1197-1203.
    View in: PubMed
    Score: 0.147
  30. TLD and OSLD dosimetry systems for remote audits of radiotherapy external beam calibration. Radiat Meas. 2017 11; 106:412-415.
    View in: PubMed
    Score: 0.145
  31. Examining credentialing criteria and poor performance indicators for IROC Houston's anthropomorphic head and neck phantom. Med Phys. 2016 Dec; 43(12):6491.
    View in: PubMed
    Score: 0.144
  32. Approaches to reducing photon dose calculation errors near metal implants. Med Phys. 2016 Sep; 43(9):5117.
    View in: PubMed
    Score: 0.141
  33. Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations. Med Phys. 2016 Aug; 43(8):4842.
    View in: PubMed
    Score: 0.140
  34. Technical Report: Reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data. Med Phys. 2016 May; 43(5):2374.
    View in: PubMed
    Score: 0.138
  35. Agreement Between Institutional Measurements and Treatment Planning System Calculations for Basic Dosimetric Parameters as Measured by the Imaging and Radiation Oncology Core-Houston. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1527-1534.
    View in: PubMed
    Score: 0.137
  36. Results From the Imaging and Radiation Oncology Core Houston's Anthropomorphic Phantoms Used for Proton Therapy Clinical Trial Credentialing. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):242-248.
    View in: PubMed
    Score: 0.136
  37. Characterization of the nanoDot OSLD dosimeter in CT. Med Phys. 2015 Apr; 42(4):1797-807.
    View in: PubMed
    Score: 0.128
  38. An evaluation of three commercially available metal artifact reduction methods for CT imaging. Phys Med Biol. 2015 Feb 07; 60(3):1047-67.
    View in: PubMed
    Score: 0.126
  39. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans. Med Phys. 2014 Dec; 41(12):121702.
    View in: PubMed
    Score: 0.125
  40. A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites. J Appl Clin Med Phys. 2014 Sep 08; 15(5):4935.
    View in: PubMed
    Score: 0.123
  41. Effects of spatial resolution and noise on gamma analysis for IMRT QA. J Appl Clin Med Phys. 2014 Jul 08; 15(4):4690.
    View in: PubMed
    Score: 0.122
  42. Reproducibility in patient-specific IMRT QA. J Appl Clin Med Phys. 2014 May 08; 15(3):4741.
    View in: PubMed
    Score: 0.120
  43. Comparison of 2D and 3D gamma analyses. Med Phys. 2014 Feb; 41(2):021710.
    View in: PubMed
    Score: 0.118
  44. Investigation of various energy deposition kernel refinements for the convolution/superposition method. Med Phys. 2013 Dec; 40(12):121721.
    View in: PubMed
    Score: 0.117
  45. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry. Med Phys. 2013 Nov; 40(11):112102.
    View in: PubMed
    Score: 0.116
  46. Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials. J Appl Clin Med Phys. 2013 Jul 08; 14(4):4313.
    View in: PubMed
    Score: 0.114
  47. Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity-modulated radiation therapy treatments. J Appl Clin Med Phys. 2013 Mar 04; 14(2):4139.
    View in: PubMed
    Score: 0.111
  48. The Radiological Physics Center's standard dataset for small field size output factors. J Appl Clin Med Phys. 2012 08 08; 13(5):3962.
    View in: PubMed
    Score: 0.107
  49. SU-E-T-86: Development and Implementation of the Use of Optically Stimulated Luminescent Detectors in the Radiological Physics Center Anthropomorphic Quality Assurance Phantoms. Med Phys. 2012 Jun; 39(6Part11):3722.
    View in: PubMed
    Score: 0.105
  50. SU-E-T-223: High-Energy Photon Standard Dosimetry Data: A Quality Assurance Tool. Med Phys. 2012 Jun; 39(6Part13):3754.
    View in: PubMed
    Score: 0.105
  51. SU-E-T-447: Evaluation of the Anisotropic Analytical Algorithm (AAA) Heterogeneity Correction Dose Calculation in Flattened and Flattening- Filter-Free (FFF) Beams for High Energy X-Ray Beams Using the Radiological Physics Center (RPC) Lung Phantom. Med Phys. 2012 Jun; 39(6Part17):3807.
    View in: PubMed
    Score: 0.105
  52. SU-E-T-190: Design, Development, and Evaluation of a Modified, Anthropomorphic, Head, Quality Assurance Phantom for Use in Stereotactic Radiosurgery. Med Phys. 2012 Jun; 39(6Part12):3746-3747.
    View in: PubMed
    Score: 0.105
  53. MO-D-BRB-02: The Radiological Physics Center's Quality Audit Program: Where Can We Improve? Med Phys. 2012 Jun; 39(6Part21):3866.
    View in: PubMed
    Score: 0.105
  54. MO-D-BRB-05: An Analysis of 13,000 Patient-Specific IMRT QA Results from 13 Different Clinical Treatment Services. Med Phys. 2012 Jun; 39(6Part21):3866-3867.
    View in: PubMed
    Score: 0.105
  55. Energy response of optically stimulated luminescent dosimeters for non-reference measurement locations in a 6 MV photon beam. Phys Med Biol. 2012 May 07; 57(9):2505-15.
    View in: PubMed
    Score: 0.104
  56. Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer. Radiat Oncol. 2012 Feb 08; 7:19.
    View in: PubMed
    Score: 0.103
  57. Erratum: "Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators" [Med. Phys. 36(9), 4027-4038 (2009)]. Med Phys. 2011 Dec; 38(12):6789.
    View in: PubMed
    Score: 0.102
  58. The clinical impact of the couch top and rails on IMRT and arc therapy. Phys Med Biol. 2011 Dec 07; 56(23):7435-47.
    View in: PubMed
    Score: 0.101
  59. Variations in photon energy spectra of a 6 MV beam and their impact on TLD response. Med Phys. 2011 May; 38(5):2619-28.
    View in: PubMed
    Score: 0.098
  60. Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. Med Phys. 2009 Sep; 36(9):4027-38.
    View in: PubMed
    Score: 0.087
  61. The use of LiF (TLD-100) as an out-of-field dosimeter. J Appl Clin Med Phys. 2007 Sep 24; 8(4):169-175.
    View in: PubMed
    Score: 0.076
  62. A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. Med Phys. 2007 Sep; 34(9):3489-99.
    View in: PubMed
    Score: 0.076
  63. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Jul 15; 68(4):1265-71.
    View in: PubMed
    Score: 0.075
  64. A Monte Carlo model for calculating out-of-field dose from a varian 6 MV beam. Med Phys. 2006 Nov; 33(11):4405-13.
    View in: PubMed
    Score: 0.071
  65. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005 Jul 15; 62(4):1195-203.
    View in: PubMed
    Score: 0.065
  66. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2005 Jul 15; 62(4):1204-16.
    View in: PubMed
    Score: 0.065
  67. Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators. J Appl Clin Med Phys. 2003; 4(3):189-94.
    View in: PubMed
    Score: 0.055
  68. Body region-specific 3D age-scaling functions for scaling whole-body computed tomography anatomy for pediatric late effects studies. Biomed Phys Eng Express. 2022 02 01; 8(2).
    View in: PubMed
    Score: 0.051
  69. Quality assurance in radiation oncology. Pediatr Blood Cancer. 2021 05; 68 Suppl 2:e28609.
    View in: PubMed
    Score: 0.049
  70. Our Experience Leading a Large Medical Physics Practice During the COVID-19 Pandemic. Adv Radiat Oncol. 2021 Jul-Aug; 6(4):100683.
    View in: PubMed
    Score: 0.049
  71. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. 2020 12; 153:163-171.
    View in: PubMed
    Score: 0.047
  72. A Mail Audit Independent Peer Review System for Dosimetry Verification of a Small Animal Irradiator. Radiat Res. 2020 04; 193(4):341-350.
    View in: PubMed
    Score: 0.045
  73. Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG-203?. Med Phys. 2019 Dec; 46(12):e757-e788.
    View in: PubMed
    Score: 0.044
  74. A comparison of IROC and ACDS on-site audits of reference and non-reference dosimetry. Med Phys. 2019 Dec; 46(12):5878-5887.
    View in: PubMed
    Score: 0.044
  75. Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies. Acta Oncol. 2019 Dec; 58(12):1731-1739.
    View in: PubMed
    Score: 0.043
  76. The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols. Int J Radiat Oncol Biol Phys. 2018 11 15; 102(4):775-782.
    View in: PubMed
    Score: 0.041
  77. A multinational audit of small field output factors calculated by treatment planning systems used in radiotherapy. Phys Imaging Radiat Oncol. 2018 Jan; 5:58-63.
    View in: PubMed
    Score: 0.039
  78. Angular dependence of the nanoDot OSL dosimeter. Med Phys. 2011 Jul; 38(7):3955-62.
    View in: PubMed
    Score: 0.025
  79. Effects of tertiary MLC configuration on secondary neutron spectra from 18 MV x-ray beams for the Varian 21EX linear accelerator. Med Phys. 2009 Sep; 36(9):4039-46.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.